Lp(a)
Lp(a) is a heart-risk number that’s almost entirely set by your genes. You only need to test it once in your life — and if it’s high, the focus shifts to everything else you can control.
Lp(a) is a type of LDL particle with extra clot-promoting protein attached. About 20% of people have elevated levels — higher in South Asians. Your level is genetically locked, so one test tells you where you stand for life.
What is the Lp(a) test?
Think of Lp(a) — pronounced "L-P-little-a" — as a rogue LDL particle. It looks like regular LDL but has an extra protein bolted on that makes it stickier in your arteries and more likely to cause clots. Your body makes a specific amount based on your genes, and that amount barely changes throughout your life.
This is why cardiologists call it the most important genetic heart risk factor after familial high cholesterol. And it’s especially relevant if you’re South Asian — average Lp(a) levels are higher in Indian populations.
What your number means
| Lp(a) Level | What it means | What to do |
|---|---|---|
| <30 mg/dL (<75 nmol/L) | Low risk | Lp(a) isn’t a concern for you. Standard heart-health basics. |
| 30–50 mg/dL (75–125 nmol/L) | Borderline | Worth noting. Optimise ApoB, blood pressure, and inflammation. |
| 50–100 mg/dL (125–250 nmol/L) | High | Aggressively optimise every other modifiable risk factor. |
| >100 mg/dL (>250 nmol/L) | Very high | Cardiologist referral. Discuss PCSK9 inhibitors. |
Ask your lab to report in nmol/L if possible — the mg/dL conversion is inconsistent between labs.
How to improve it
Very little can lower Lp(a) directly. Diet, exercise, and most supplements don’t move it. Statins don’t lower it (and may slightly raise it). The focus should be on aggressively optimising everything else you can control — ApoB, blood pressure, blood sugar, inflammation, and smoking cessation.
Each modifiable risk factor you improve directly reduces the absolute danger from elevated Lp(a).
What’s in the pipeline: New RNA-targeting drugs (pelacarsen, olpasiran) show 80–90% Lp(a) reduction in trials. Not yet approved, but potentially transformative when they arrive.
Want to track your Lp(a)?
eterni connects your lab results into a trajectory — so you can see if your overall risk profile is improving, not just a single number.
Get early accessFrequently Asked Questions
Do I need to test Lp(a) more than once?
No — your Lp(a) is genetically determined and stays essentially the same your whole life. One test is enough. The only exception is if you’re on a treatment specifically targeting Lp(a), like a PCSK9 inhibitor.
Can I lower Lp(a) with diet or supplements?
Unfortunately, diet, exercise, and most supplements have minimal impact on Lp(a). Niacin (1–2g/day) can reduce it 20–30% but has side effects. PCSK9 inhibitors lower it 25–30%. New RNA therapies show 80–90% reduction but aren’t approved yet. The strategy is to optimise all other heart risk factors.
How much does the Lp(a) test cost in India?
₹600–1,200 at major labs like SRL, Metropolis, and Dr Lal PathLabs. Ask for results in nmol/L — it’s more standardised than mg/dL.
Is Lp(a) more common in Indians?
Yes — South Asians have higher average Lp(a) levels compared to European populations. This compounds the already elevated cardiovascular risk profile. If you’re Indian, Lp(a) testing should be a standard part of your heart-health check.
How Lp(a) causes damage
Lp(a) is both atherogenic (builds plaque in your arteries like LDL) and thrombogenic (promotes blood clots). The extra apo(a) protein structurally resembles plasminogen, the molecule your body uses to dissolve clots — so Lp(a) may actually interfere with clot breakdown. This dual mechanism is why elevated Lp(a) is linked to heart attacks, strokes, and aortic valve stenosis.
Clinical vs optimal ranges
Many labs report anything under 30 mg/dL as "normal" but the cardiovascular risk is continuous — lower is better. The European Atherosclerosis Society considers >50 mg/dL (>125 nmol/L) elevated. For longevity-focused assessment, <30 mg/dL (<75 nmol/L) is the target.
India-specific context
South Asians get coronary artery disease at younger ages and lower LDL levels than Western populations. Elevated Lp(a) is one reason. The INTERHEART study confirmed Lp(a) as an independent risk factor across South Asian populations. Testing should be standard for any Indian adult concerned about heart health.
Connected supplements
While no supplement meaningfully lowers Lp(a), optimising other cardiovascular markers with omega-3 (for triglycerides), berberine (for blood sugar), and CoQ10 (for statin users) reduces your overall risk burden.
Know what's working. Know what's not.
eterni connects your lab results, supplements, and retests — so you can see the trajectory, not just a snapshot.
Join the waitlist